Company Filing History:
Years Active: 2002-2004
Title: The Innovations of Michael Lochrie
Introduction
Michael Lochrie is an accomplished inventor based in Louisville, Colorado. He has made significant contributions to the field of biotechnology, particularly in the development of nucleic acid ligands and inhibitors. With a total of 3 patents to his name, Lochrie's work has the potential to impact various therapeutic applications.
Latest Patents
Lochrie's latest patents include innovative methods for the identification and preparation of high-affinity nucleic acid ligands to TGF&bgr;2. These patents describe specific RNA ligands to TGF&bgr;2 that were identified using the SELEX method. Additionally, his inventions include RNA ligands that inhibit the interaction of TGF&bgr;2 with its receptor, showcasing his expertise in this specialized area of research.
Career Highlights
Michael Lochrie is currently employed at Gilead Sciences, Inc., where he continues to advance his research in biotechnology. His work at Gilead has allowed him to collaborate with leading experts in the field, further enhancing the impact of his inventions.
Collaborations
Some of Lochrie's notable coworkers include Larry M Gold and Nikos C Pagratis. Their collaboration has contributed to the innovative research environment at Gilead Sciences, Inc.
Conclusion
Michael Lochrie's contributions to biotechnology through his patents and research at Gilead Sciences, Inc. highlight his role as a significant inventor in the field. His work on high-affinity nucleic acid ligands and inhibitors demonstrates the potential for advancements in therapeutic applications.